 JUPITER, Fla., Feb. 1, 2021 PRNewswire -- Marizyme, Inc. OTCQB:MRZM, a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has... 